Ocular disorders resulting from treatment with practolol (Eraldin) [proceedings].
D005128:Eye Diseases / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008297:Male; D011217:Practolol / Q000009:adverse effects* / Q000627:therapeutic use; D013997:Time Factors
D011217:Practolol